Status:
COMPLETED
Does Medical Cannabis Reduce Opioid Use in Adults With Pain
Lead Sponsor:
Albert Einstein College of Medicine
Collaborating Sponsors:
Laura and John Arnold Foundation
Vireo Health
Conditions:
Opioid Use
Marijuana
Eligibility:
All Genders
18-99 years
Brief Summary
The study will examine how medical cannabis use affects opioid analgesic use. This landmark study will be among the first to examine the effect of medical cannabis with different THC/CBD (Tetrahydroca...
Detailed Description
This study will examine how medical cannabis use affects opioid analgesic use, with particular attention to THC/CBD (Tetrahydrocannibinol/Cannabidiol) content and adverse events. We will enroll adults...
Eligibility Criteria
Inclusion
- At least 18 years of age
- English or Spanish fluency
- Actively certified for medical cannabis
- Intends to have a soft-gel capsule product dispensed at Vireo
- Medical cannabis qualifying conditions or complications of "chronic or severe pain" or "pain that degrades health and functional capability as an alternative to opioid use or substance use disorder"
- Joint or neuropathic pain
- Current severe pain
- Dispensed opioid analgesics within the last 60 days
- To maintain the integrity of the study, we do not disclose all inclusion criteria to potential participants.
Exclusion
- Inability to provide informed consent
- Inability to complete study visits over 14 weeks
- Terminal illness
- Current or prior psychotic disorder
- Buprenorphine or methadone treatment for opioid use disorder within the past year
- Allergies to tapioca or coconut
- Currently pregnant, planning to become pregnant within the next 3 months, or breastfeeding
- Condition that is considered by a pharmacist or medical provider to be a contraindication to medical cannabis use (e.g. unstable cardiac arrhythmia or specific drug-use interaction)
Key Trial Info
Start Date :
October 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 13 2024
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT04308148
Start Date
October 6 2020
End Date
March 13 2024
Last Update
March 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Health System
The Bronx, New York, United States, 10451